4//SEC Filing
Plinio Mark D. 4
Accession 0001694665-21-000092
CIK 0001694665other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:18 PM ET
Size
5.5 KB
Accession
0001694665-21-000092
Insider Transaction Report
Form 4
Plinio Mark D.
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-14+250,000→ 250,000 totalExercise: $16.34Exp: 2031-06-14→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]25% of underlying shares will vest on 1st anniversary of employment commencement date (i.e., June 14, 2022), and remaining 75% of underlying shares will vest in 36 substantially equal monthly installments thereafter
Documents
Issuer
Evelo Biosciences, Inc.
CIK 0001694665
Entity typeother
Related Parties
1- filerCIK 0001865558
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:18 PM ET
- Size
- 5.5 KB